1FQ9 image
Deposition Date 2000-09-04
Release Date 2000-09-27
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1FQ9
Title:
CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.28
R-Value Work:
0.22
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:FIBROBLAST GROWTH FACTOR 2
Gene (Uniprot):FGF2
Mutations:C69S, C87S
Chain IDs:A, B
Chain Length:132
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:FIBROBLAST GROWTH FACTOR RECEPTOR 1
Gene (Uniprot):FGFR1
Mutations:N185Q
Chain IDs:C, D
Chain Length:225
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
Mol.Cell 6 743 750 (2000)
PMID: 11030354 DOI: 10.1016/S1097-2765(00)00073-3

Abstact

The crystal structure of a dimeric 2:2:2 FGF:FGFR:heparin ternary complex at 3 A resolution has been determined. Within each 1:1 FGF:FGFR complex, heparin makes numerous contacts with both FGF and FGFR, thereby augmenting FGF-FGFR binding. Heparin also interacts with FGFR in the adjoining 1:1 FGF:FGFR complex to promote FGFR dimerization. The 6-O-sulfate group of heparin plays a pivotal role in mediating both interactions. The unexpected stoichiometry of heparin binding in the structure led us to propose a revised model for FGFR dimerization. Biochemical data in support of this model are also presented. This model provides a structural basis for FGFR activation by small molecule heparin analogs and may facilitate the design of heparin mimetics capable of modulating FGF signaling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures